Concepts (54)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lymphocytes, Tumor-Infiltrating | 3 | 2023 | 155 | 0.380 |
Why?
|
| Urinary Tract Infections | 2 | 2026 | 342 | 0.330 |
Why?
|
| Vagina | 2 | 2026 | 208 | 0.260 |
Why?
|
| Mucous Membrane | 1 | 2026 | 95 | 0.240 |
Why?
|
| Melanoma | 2 | 2023 | 931 | 0.230 |
Why?
|
| Immunity, Mucosal | 1 | 2026 | 95 | 0.230 |
Why?
|
| Streptococcus agalactiae | 1 | 2026 | 106 | 0.230 |
Why?
|
| Uromodulin | 1 | 2025 | 12 | 0.220 |
Why?
|
| Extracellular Traps | 1 | 2025 | 11 | 0.220 |
Why?
|
| Clinical Medicine | 1 | 2024 | 20 | 0.200 |
Why?
|
| Streptococcal Infections | 1 | 2026 | 254 | 0.200 |
Why?
|
| Cytokines | 2 | 2026 | 1339 | 0.200 |
Why?
|
| Pregnancy Outcome | 1 | 2026 | 623 | 0.190 |
Why?
|
| Neutrophils | 1 | 2025 | 371 | 0.180 |
Why?
|
| Microbiota | 2 | 2026 | 438 | 0.180 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2022 | 57 | 0.170 |
Why?
|
| Neoplasms, Second Primary | 1 | 2022 | 142 | 0.170 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2026 | 514 | 0.170 |
Why?
|
| Penile Neoplasms | 1 | 2021 | 19 | 0.170 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2021 | 463 | 0.130 |
Why?
|
| Graft vs Host Disease | 1 | 2022 | 694 | 0.120 |
Why?
|
| Papillomavirus Infections | 1 | 2021 | 394 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2026 | 1459 | 0.110 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2021 | 750 | 0.110 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2022 | 1280 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 3 | 2026 | 4738 | 0.090 |
Why?
|
| Mice | 4 | 2026 | 18301 | 0.070 |
Why?
|
| Uropathogenic Escherichia coli | 1 | 2026 | 31 | 0.060 |
Why?
|
| Immunotherapy, Adoptive | 2 | 2023 | 960 | 0.060 |
Why?
|
| Th17 Cells | 1 | 2026 | 101 | 0.060 |
Why?
|
| Interleukin-10 | 1 | 2026 | 192 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2026 | 4697 | 0.050 |
Why?
|
| Animals | 4 | 2026 | 33912 | 0.050 |
Why?
|
| Metagenome | 1 | 2024 | 138 | 0.050 |
Why?
|
| Pregnancy | 2 | 2026 | 7512 | 0.050 |
Why?
|
| Premature Birth | 1 | 2026 | 428 | 0.040 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2022 | 151 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2023 | 500 | 0.040 |
Why?
|
| Transplantation Conditioning | 1 | 2022 | 328 | 0.040 |
Why?
|
| Lymphatic Metastasis | 1 | 2021 | 426 | 0.040 |
Why?
|
| Cyclophosphamide | 1 | 2022 | 428 | 0.040 |
Why?
|
| Humans | 7 | 2026 | 131163 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2021 | 357 | 0.040 |
Why?
|
| Neoadjuvant Therapy | 1 | 2021 | 400 | 0.040 |
Why?
|
| Female | 4 | 2026 | 70963 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2025 | 3819 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2023 | 6459 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 6797 | 0.020 |
Why?
|
| Male | 2 | 2026 | 64957 | 0.020 |
Why?
|
| United States | 1 | 2022 | 12072 | 0.010 |
Why?
|
| Aged | 1 | 2021 | 21025 | 0.010 |
Why?
|
| Child | 1 | 2022 | 26341 | 0.010 |
Why?
|
| Middle Aged | 1 | 2021 | 28601 | 0.010 |
Why?
|
| Adult | 1 | 2021 | 31282 | 0.010 |
Why?
|